{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:40:05Z","timestamp":1781271605908,"version":"3.54.1"},"reference-count":55,"publisher":"BMFH Press","issue":"2","funder":[{"name":"CMU Junior Research Followship Program, Chiang Mai University, Chiang Mai, Thailand","award":["JRCMU2566R_109"],"award-info":[{"award-number":["JRCMU2566R_109"]}]},{"name":"Program Management Unit for Competitiveness","award":["189773-C02F680003"],"award-info":[{"award-number":["189773-C02F680003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.12938\/bmfh.2024-074","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T22:13:21Z","timestamp":1734387201000},"page":"160-170","source":"Crossref","is-referenced-by-count":5,"title":["Administration of a probiotic supplement attenuates nonalcoholic fatty liver disease by reducing hepatic lipid accumulation, oxidative stress, and inflammation"],"prefix":"10.12938","volume":"44","author":[{"given":"Pennapa","family":"CHONPATHOMPIKUNLERT","sequence":"first","affiliation":[{"name":"Biodiversity Research Centre (BRC), Thailand Institute of Scientific and              Technological Research (TISTR), Pathumthani 12120, Thailand"},{"name":"Pre-clinical and Clinical Research Service Unit (P2CRSU), A Division of              Research and Development Group for Bio-Industries, Thailand Institute of Scientific              and Technological Research (TISTR), Pathumthani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratoomporn","family":"YINGTHONGCHAI","sequence":"additional","affiliation":[{"name":"Multidisciplinary Research Institute, Chiang Mai University, Chiang Mai              50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suriya","family":"TATEING","sequence":"additional","affiliation":[{"name":"Department of Plant and Soil Sciences, Faculty of Agriculture, Chiang Mai              University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuwat","family":"AMATACHAYA","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Science, Khon Kaen University, Khon Kaen              40002, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasalux","family":"KAEWBUTRA","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Amnatcharoen Campus, Mahidol University,              Amnat Charoen 37000, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neungnut","family":"CHAIYAWAN","sequence":"additional","affiliation":[{"name":"Biodiversity Research Centre (BRC), Thailand Institute of Scientific and              Technological Research (TISTR), Pathumthani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyarat","family":"LEKCHAOUM","sequence":"additional","affiliation":[{"name":"Biodiversity Research Centre (BRC), Thailand Institute of Scientific and              Technological Research (TISTR), Pathumthani 12120, Thailand"},{"name":"Pre-clinical and Clinical Research Service Unit (P2CRSU), A Division of              Research and Development Group for Bio-Industries, Thailand Institute of Scientific              and Technological Research (TISTR), Pathumthani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaivarakun","family":"CHAIPANYA","sequence":"additional","affiliation":[{"name":"Biodiversity Research Centre (BRC), Thailand Institute of Scientific and              Technological Research (TISTR), Pathumthani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wachirawadee","family":"MALAKUL","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medical Science, Naresuan University,              Phitsanulok 65000, Thailand"},{"name":"Centre of Excellence in Medical Biotechnology, Naresuan University,              Phitsanulok 65000, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurairat","family":"KHONGRUM","sequence":"additional","affiliation":[{"name":"Multidisciplinary Research Institute, Chiang Mai University, Chiang Mai              50200, Thailand"},{"name":"Functional Food Research Center for Well-Being, Chiang Mai University,              Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5076","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Angulo              P, Lindor              KD. 2002.            Non-alcoholic fatty liver disease. J            Gastroenterol Hepatol 17 Suppl:            S186\u2013S190.","DOI":"10.1046\/j.1440-1746.17.s1.10.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zarghamravanbakhsh              P, Frenkel              M, Poretsky              L. 2021.            Metabolic causes and consequences of nonalcoholic fatty liver disease            (NAFLD). Metab Open 12:            100149.","DOI":"10.1016\/j.metop.2021.100149"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Targher              G, Marra              F, Marchesini              G. 2008.            Increased risk of cardiovascular disease in non-alcoholic fatty liver            disease: causal effect or            epiphenomenon? Diabetologia 51:            1947\u20131953.","DOI":"10.1007\/s00125-008-1135-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fang              J,                Celton-Morizur              S, Desdouets              C. 2023.            NAFLD-related HCC: focus on the latest relevant preclinical            models. Cancers (Basel) 15:            3723.","DOI":"10.3390\/cancers15143723"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lim              JS,                Mietus-Snyder              M, Valente              A, Schwarz              JM, Lustig              RH. 2010.            The role of fructose in the pathogenesis of NAFLD and the metabolic            syndrome. Nat Rev Gastroenterol Hepatol 7: 251\u2013264.","DOI":"10.1038\/nrgastro.2010.41"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wahlang              B, Jin              J, Beier              JI, Hardesty              JE, Daly              EF,                Schnegelberger              RD, Falkner              KC, Prough              RA, Kirpich              IA, Cave              MC. 2019.            Mechanisms of environmental contributions to fatty liver            disease. Curr Environ Health Rep 6:            80\u201394.","DOI":"10.1007\/s40572-019-00232-w"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Miyazaki              M, Flowers              MT, Sampath              H, Chu              K,                Otzelberger              C, Liu              X, Ntambi              JM. 2007.            Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from            carbohydrate-induced adiposity and hepatic steatosis. Cell            Metab 6: 484\u2013496.","DOI":"10.1016\/j.cmet.2007.10.014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Svendsen              P, Graversen              JH, Etzerodt              A, Hager              H, R\u00f8ge              R, Gr\u00f8nb\u00e6k              H,                Christensen              EI, M\u00f8ller              HJ, Vilstrup              H, Moestrup              SK. 2016.            Antibody-directed glucocorticoid targeting to cd163 in m2-type            macrophages attenuates fructose-induced liver inflammatory changes.            Mol Ther Methods Clin Dev 4:            50\u201361.","DOI":"10.1016\/j.omtm.2016.11.004"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Federico              A, Rosato              V, Masarone              M, Torre              P, Dallio              M, Romeo              M, Persico              M. 2021.            The role of fructose in non-alcoholic steatohepatitis: old relationship            and new insights. Nutrients 13:            1314.","DOI":"10.3390\/nu13041314"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Geidl-Flueck              B, Gerber              PA. 2023.            Fructose drives de novo lipogenesis affecting metabolic            health. J Endocrinol 257:            e220270.","DOI":"10.1530\/JOE-22-0270"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sodhi              K, Puri              N, Favero              G, Stevens              S, Meadows              C, Abraham              NG, Rezzani              R, Ansinelli              H, Lebovics              E, Shapiro              JI. 2015.            Fructose mediated non-alcoholic fatty liver is attenuated by HO-1-SIRT1            module in murine hepatocytes and mice fed a high fructose diet.            PLoS One 10: e0128648.","DOI":"10.1371\/journal.pone.0128648"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wang              Y, Qi              W, Song              G, Pang              S, Peng              Z, Li              Y, Wang              P. 2020.            High-fructose diet increases inflammatory cytokines and alters gut            microbiota composition in rats. Mediators            Inflamm 2020: 6672636.","DOI":"10.1155\/2020\/6672636"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Cesaro              C, Tiso              A, Del Prete              A, Cariello              R, Tuccillo              C, Cotticelli              G, Del Vecchio                Blanco              C, Loguercio              C. 2011.            Gut microbiota and probiotics in chronic liver diseases.            Dig Liver Dis 43:            431\u2013438.","DOI":"10.1016\/j.dld.2010.10.015"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Werlinger              P, Nguyen              HT, Gu              M, Cho              JH, Cheng              J, Suh              JW. 2022.              <i>Lactobacillus reuteri<\/i> MJM60668 prevent progression of            non-alcoholic fatty liver disease through anti-adipogenesis and anti-inflammatory            pathway. Microorganisms 10:            2203.","DOI":"10.3390\/microorganisms10112203"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hsieh              FC, Lee              CL, Chai              CY, Chen              WT, Lu              YC, Wu              CS. 2013.            Oral administration of <i>Lactobacillus reuteri<\/i> GMNL-263            improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed            rats. Nutr Metab (Lond) 10:            35.","DOI":"10.1186\/1743-7075-10-35"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Hathout              AS, Mohamed              SR,                El-Nekeety              AA, Hassan              NS, Aly              SE,                Abdel-Wahhab              MA. 2011.            Ability of <i>Lactobacillus casei<\/i> and <i>Lactobacillus              reuteri<\/i> to protect against oxidative stress in rats fed            aflatoxins-contaminated diet. Toxicon 58: 179\u2013186.","DOI":"10.1016\/j.toxicon.2011.05.015"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chen              Y, Liu              S, Yu              C, Azevedo              P, Liu              S, O K, Gong J, Hou Y, Yang C.            2021. Evaluating the effectiveness of <i>Lactobacillus              zeae<\/i> against enterotoxigenic <i>Escherichia coli<\/i> F4 infection            in an <i>in vitro<\/i> porcine intestinal epithelial cell          model. ACS Food Sci Technol 1:            215\u2013228.","DOI":"10.1021\/acsfoodscitech.0c00069"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zhou              M, Liu              X, Yu              H, Gong              J. 2021.              <i>Lactobacillus<\/i> regulates <i>Caenorhabditis              elegans<\/i> cell signaling to combat <i>salmonella<\/i>            infection. Front Immunol 12:            653205.","DOI":"10.3389\/fimmu.2021.653205"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mamikutty              N, Thent              ZC, Sapri              SR, Sahruddin              NN, Mohd                Yusof              MR, Haji                Suhaimi              F. 2014.            The establishment of metabolic syndrome model by induction of fructose            drinking water in male Wistar rats. BioMed Res            Int 2014: 263897.","DOI":"10.1155\/2014\/263897"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Friedewald              WT, Levy              RI,                Fredrickson              DS. 1972.            Estimation of the concentration of low-density lipoprotein cholesterol in            plasma, without use of the preparative ultracentrifuge. Clin            Chem 18: 499\u2013502.","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ohkawa              H, Ohishi              N, Yagi              K. 1979.            Assay for lipid peroxides in animal tissues by thiobarbituric acid            reaction. Anal Biochem 95:            351\u2013358.","DOI":"10.1016\/0003-2697(79)90738-3"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Gunadi              JW, Tarawan              VM, Daniel                Ray              HR,                Wahyudianingsih              R, Lucretia              T, Tanuwijaya              F, Lesmana              R, Supratman              U, Setiawan              I. 2020.            Different training intensities induced autophagy and histopathology            appearances potentially associated with lipid metabolism in wistar rat            liver. Heliyon 6:            e03874.","DOI":"10.1016\/j.heliyon.2020.e03874"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Ackerman              Z,                Oron-Herman              M, Grozovski              M, Rosenthal              T, Pappo              O, Link              G, Sela              BA. 2005.            Fructose-induced fatty liver disease: hepatic effects of blood pressure            and plasma triglyceride reduction. Hypertension 45: 1012\u20131018.","DOI":"10.1161\/01.HYP.0000164570.20420.67"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kawasaki              T, Igarashi              K, Koeda              T, Sugimoto              K, Nakagawa              K, Hayashi              S, Yamaji              R, Inui              H, Fukusato              T, Yamanouchi              T. 2009.            Rats fed fructose-enriched diets have characteristics of nonalcoholic            hepatic steatosis. J Nutr 139:            2067\u20132071.","DOI":"10.3945\/jn.109.105858"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Ter Horst              KW, Serlie              MJ. 2017.            Fructose consumption, lipogenesis, and non-alcoholic fatty liver            disease. Nutrients 9:            981.","DOI":"10.3390\/nu9090981"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Choi              Y,                Abdelmegeed              MA, Song              BJ. 2017.            Diet high in fructose promotes liver steatosis and hepatocyte apoptosis            in C57BL\/6J female mice: role of disturbed lipid homeostasis and increased oxidative            stress. Food Chem Toxicol 103:            111\u2013121.","DOI":"10.1016\/j.fct.2017.02.039"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Jegatheesan              P, De Bandt              JP. 2017.            Fructose and NAFLD: the multifaceted aspects of fructose            metabolism. Nutrients 9:            230.","DOI":"10.3390\/nu9030230"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Arroyave-Ospina              JC, Wu              Z, Geng              Y, Moshage              H. 2021.            Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver            disease: implications for prevention and therapy.            Antioxidants 10: 174.","DOI":"10.3390\/antiox10020174"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Duan              Y, Pan              X, Luo              J, Xiao              X, Li              J, Bestman              PL, Luo              M. 2022.            Association of inflammatory cytokines with non-alcoholic fatty liver            disease. Front Immunol 13:            880298.","DOI":"10.3389\/fimmu.2022.880298"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kakino              S, Ohki              T, Nakayama              H, Yuan              X, Otabe              S, Hashinaga              T, Wada              N, Kurita              Y, Tanaka              K, Hara              K, et            al. 2018. Pivotal role of TNF-\u03b1 in the            development and progression of nonalcoholic fatty liver disease in a murine            model. Horm Metab Res 50:            80\u201387.","DOI":"10.1055\/s-0043-118666"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Knebel              B, Haas              J, Hartwig              S, Jacob              S, K\u00f6llmer              C, Nitzgen              U,                Muller-Wieland              D, Kotzka              J. 2012.            Liver-specific expression of transcriptionally active SREBP-1c is            associated with fatty liver and increased visceral fat mass.            PLoS One 7: e31812.","DOI":"10.1371\/journal.pone.0031812"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Panasevich              MR, Meers              GM, Linden              MA, Booth              FW, Perfield              JW              2nd, Fritsche              KL, Wankhade              UD,                Chintapalli              SV, Shankar              K, Ibdah              JA, et            al. 2018. High-fat, high-fructose,            high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile            Ossabaw swine. Am J Physiol Endocrinol Metab 314: E78\u2013E92.","DOI":"10.1152\/ajpendo.00015.2017"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Wouters              K, van Gorp              PJ, Bieghs              V, Gijbels              MJ, Duimel              H, L\u00fctjohann              D, Kerksiek              A, van                Kruchten              R, Maeda              N, Staels              B, et            al. 2008. Dietary cholesterol, rather            than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of            nonalcoholic steatohepatitis. Hepatology 48: 474\u2013486.","DOI":"10.1002\/hep.22363"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Liang              JQ, Teoh              N, Xu              L, Pok              S, Li              X, Chu              ESH, Chiu              J, Dong              L, Arfianti              E, Haigh              WG, et            al. 2018. Dietary cholesterol promotes            steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and            calcium signaling. Nat Commun 9:            4490.","DOI":"10.1038\/s41467-018-06931-6"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Rahman              K, Desai              C, Iyer              SS, Thorn              NE, Kumar              P, Liu              Y, Smith              T, Neish              AS, Li              H, Tan              S, et            al. 2016. Loss of junctional adhesion            molecule a promotes severe steatohepatitis in mice on a diet high in saturated fat,            fructose, and cholesterol. Gastroenterology 151: 733\u2013746.e12.","DOI":"10.1053\/j.gastro.2016.06.022"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Aziz              M, Hemeda              SA, Albadrani              GM, Fadl              SE, Elgendey              F. 2023.            Ameliorating effect of probiotic on nonalcoholic fatty liver disease and            lipolytic gene expression in rabbits. Sci Rep 13: 6312.","DOI":"10.1038\/s41598-023-32584-7"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Sitdhipol              J,                Niwasabutra              K, Chaiyawan              N, Teerawet              S,                Thaveethaptaikul              P,                Phuengjayaem              S,                Taweechotipatr              M,                Tanasupawat              S,                Phapugrangkul              P. 2023.            Probiotic characterization and <i>in vitro<\/i> functional            properties of lactic acid bacteria isolated in Thailand. Sci            Asia 49: 29\u201337.","DOI":"10.2306\/scienceasia1513-1874.2022.129"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Zhang              Q, Zhang              L, Lyu              Y, Shi              Y, Zhu              L, Zhang              M, Zhao              Y, Zhao              D, Wang              L, Yi              D, et            al. 2022. Dietary supplementation of              <i>Lactobacillus zeae<\/i> regulated the gut microbiome in piglets infected            with enterotoxigenic <i>Escherichia coli<\/i>. Czech J            Anim Sci 67: 27\u201338.","DOI":"10.17221\/136\/2021-CJAS"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Behary              J, Amorim              N, Jiang              XT, Raposo              A, Gong              L, McGovern              E, Ibrahim              R, Chu              F, Stephens              C, Jebeili              H, et            al. 2021. Gut microbiota impact on the            peripheral immune response in non-alcoholic fatty liver disease related hepatocellular            carcinoma. Nat Commun 12:            187.","DOI":"10.1038\/s41467-020-20422-7"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Gupta              H, Min              BH, Ganesan              R, Gebru              YA, Sharma              SP, Park              E, Won              SM, Jeong              JJ, Lee              SB, Cha              MG, et            al. 2022. Gut microbiome in            non-alcoholic fatty liver disease: from mechanisms to therapeutic role.            Biomedicines 10: 550.","DOI":"10.3390\/biomedicines10030550"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Lee              NY, Shin              MJ, Youn              GS, Yoon              SJ, Choi              YR, Kim              HS, Gupta              H, Han              SH, Kim              BK, Lee              DY, et            al. 2021.              <i>Lactobacillus<\/i> attenuates progression of nonalcoholic            fatty liver disease by lowering cholesterol and steatosis. Clin            Mol Hepatol 27: 110\u2013124.","DOI":"10.3350\/cmh.2020.0125"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Luo              M, Yan              J, Wu              L, Wu              J, Chen              Z, Jiang              J, Chen              Z, He              B. 2021.            Probiotics alleviated nonalcoholic fatty liver disease in high-fat            diet-fed rats via gut microbiota\/FXR\/FGF15 signaling pathway. J            Immunol Res 2021: 2264737.","DOI":"10.1155\/2021\/2264737"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Song              X, Liu              Y, Zhang              X, Weng              P, Zhang              R, Wu              Z. 2023.            Role of intestinal probiotics in the modulation of lipid metabolism:            implications for therapeutic treatments. Food Sci Hum            Wellness 12: 1439\u20131449.","DOI":"10.1016\/j.fshw.2023.02.005"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Washburn              RL, Sandberg              D, Stofer              MA. 2022.            Supplementation of a single species probiotic does not affect diversity            and composition of the healthy adult gastrointestinal microbiome.            Hum Nutr Metab 28: 200148.","DOI":"10.1016\/j.hnm.2022.200148"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. He              Q, Huang              J, Zheng              T, Lin              D, Zhang              H, Li              J, Sun              Z. 2021.            Treatment with mixed probiotics induced, enhanced and diversified            modulation of the gut microbiome of healthy rats. FEMS Microbiol            Ecol 97: fiab151.","DOI":"10.1093\/femsec\/fiab151"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Zhu              Y, Jiang              J, Yue              Y, Feng              Z, Chen              J, Ye              X. 2020.            Influence of mixed probiotics on the bioactive composition, antioxidant            activity and appearance of fermented red bayberry pomace.            Lebensm Wiss Technol 133: 110076.","DOI":"10.1016\/j.lwt.2020.110076"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Deng              J, Li              Y, Zhang              J, Yang              Q. 2013.            Co-administration of <i>Bacillus subtilis<\/i> RJGP16 and              <i>Lactobacillus salivarius<\/i> B1 strongly enhances the intestinal mucosal            immunity of piglets. Res Vet Sci 94:            62\u201368.","DOI":"10.1016\/j.rvsc.2012.07.025"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. He              J, Zhang              P, Shen              L, Niu              L, Tan              Y, Chen              L, Zhao              Y, Bai              L, Hao              X, Li              X, et            al. 2020. Short-chain fatty acids and            their association with signalling pathways in inflammation, glucose and lipid            metabolism. Int J Mol Sci 21:            6356.","DOI":"10.3390\/ijms21176356"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Li              Y, Xu              S, Mihaylova              MM, Zheng              B, Hou              X, Jiang              B, Park              O, Luo              Z, Lefai              E, Shyy              JY, et            al. 2011. AMPK phosphorylates and            inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in            diet-induced insulin-resistant mice. Cell Metab 13: 376\u2013388.","DOI":"10.1016\/j.cmet.2011.03.009"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Ang              Z, Ding              JL. 2016.            GPR41 and GPR43 in obesity and inflammation\u2014protective or            causative? Front Immunol 7:            28.","DOI":"10.3389\/fimmu.2016.00028"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Priyadarshini              M, Kotlo              KU, Dudeja              PK, Layden              BT. 2018.            Role of short chain fatty acid receptors in intestinal physiology and            pathophysiology. Compr Physiol 8:            1091\u20131115.","DOI":"10.1002\/j.2040-4603.2018.tb00038.x"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Casula              E, Pisano              MB, Serreli              G, Zodio              S, Melis              MP, Corona              G, Costabile              A, Cosentino              S, Deiana              M. 2023.            Probiotic lactobacilli attenuate oxysterols-induced alteration of            intestinal epithelial cell monolayer permeability: focus on tight junction            modulation. Food Chem Toxicol 172:            113558.","DOI":"10.1016\/j.fct.2022.113558"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Zheng              J, Ahmad              AA, Yang              Y, Liang              Z, Shen              W, Feng              M, Shen              J, Lan              X, Ding              X. 2022.              <i>lactobacillus rhamnosus<\/i> CY12 enhances intestinal            barrier function by regulating tight junction protein expression, oxidative stress, and            inflammation response in Lipopolysaccharide-induced Caco-2 Cells.            Int J Mol Sci 23: 11162.","DOI":"10.3390\/ijms231911162"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Zhang              Z, Liang              X, Lv              Y, Yi              H, Chen              Y, Bai              L, Zhou              H, Liu              T, Li              R, Zhang              L. 2020.            Evaluation of probiotics for improving and regulation metabolism relevant            to type 2 diabetes in vitro. J Funct Foods 64: 103664.","DOI":"10.1016\/j.jff.2019.103664"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Hsieh              PS, Ho              HH, Hsieh              SH, Kuo              YW, Tseng              HY, Kao              HF, Wang              JY. 2020.              <i>Lactobacillus salivarius<\/i> AP-32 and              <i>Lactobacillus reuteri<\/i> GL-104 decrease glycemic levels and attenuate            diabetes-mediated liver and kidney injury in db\/db mice. BMJ            Open Diabetes Res Care 8: e001028.","DOI":"10.1136\/bmjdrc-2019-001028"}],"container-title":["Bioscience of Microbiota, Food and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/44\/2\/44_2024-074\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:44:45Z","timestamp":1743828285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/44\/2\/44_2024-074\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.12938\/bmfh.2024-074","relation":{},"ISSN":["2186-3342"],"issn-type":[{"value":"2186-3342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2024-074"}}